96 Results

People

  1. Motzer
    Motzer
  2. Bajorin
    Bajorin
  3. Bosl
    Bosl
  4. Sheinfeld
    Sheinfeld
  5. Chaganti
    Chaganti
  6. Reuter
    Reuter
  7. Mazumdar
    Mazumdar
  8. Houldsworth El Naggar
    Houldsworth El Naggar
  9. Bacik
    Bacik
  10. Herr
    Herr

Groups

  1. Survivorship Research (52)
  2. Department of Medicine (40)
  3. Solid Tumor Oncology Division (40)
  4. Genitourinary Oncology Service (38)
  5. Surgery (37)
  6. Urology (33)
  7. Department of Pathology and Laboratory Medicine (19)
  8. Pediatrics, Department of (8)
  9. Sloan Kettering Institute Faculty (8)
  10. Cell Biology Program Faculty (6)
  1. "germinoma"
Formats
  1. Journal Article (92)
  2. Conference Paper (2)
  3. Editorial (1)
  4. Review (1)
Groups
  1. Survivorship Research (52)
  2. Department of Medicine (40)
  3. Solid Tumor Oncology Division (40)
  4. Genitourinary Oncology Service (38)
  5. Surgery (37)
  6. Urology (33)

More Groups

People
  1. George Bosl (45)
  2. Robert Motzer (31)
  3. Dean Bajorin (30)
  4. Joel Sheinfeld (26)
  5. Raju Chaganti (15)
  6. Victor Reuter (14)

More People

Years
  1. 2022 (3)
  2. 2014 (1)
  3. 2011 (1)
  4. 2010 (1)
  5. 2008 (1)
  6. 2006 (1)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Journal of Urology (7)
  3. Cancer (6)
  4. Cancer Research (5)
  5. Chest Surgery Clinics of North America (5)
  6. Seminars in Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Elsevier Science, Inc. (12)
  3. Elsevier Inc. (11)
  4. Springer (8)
  5. Wiley Blackwell (8)
  6. Oxford University Press (6)

More Publishers

Results (96)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy
    Journal Article

    Murphy, B. A.; Motzer, R. J.; Mazumdar, M.; Vlamis, V.; Nisselbaum, J.; Bajorin, D.; Bosl, G. J.
    Cancer (1994)

    Fulltext@MSK | Save
  • Extragonadal germ cell tumors: A 14‐year Toronto experience
    Journal Article

    Goss, P. E.; Schwertfeger, L.; Blackstein, M. E.; Iscoe, N. A.; Ginsberg, R. J.; Simpson, W. J.; Jones, D. P.; Shepherd, F. A.
    Cancer (1994)

    Fulltext@MSK | Save
  • Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors
    Journal Article

    Motzer, R. J.; Mazumdar, M.; Gulati, S. C.; Bajorin, D. F.; Lyn, P.; Vlamis, V.; Bosl, G. J.
    JNCI: Journal of the National Cancer Institute (1993)

    Fulltext@MSK | Save
  • Molecular cytogenetic analysis of i(12p)‐negative human male germ cell tumors
    Journal Article

    Rodriguez, E.; Houldsworth, J.; Reuter, V. E.; Meltzer, P.; Zhang, J.; Trent, J. M.; Bosl, G. J.; Chaganti, R. S. K.
    Genes Chromosomes and Cancer (1993)

    Fulltext@MSK | Save
  • Suramin for germ cell tumors: In vitro growth inhibition and results of a phase II trial
    Journal Article

    Motzer, R. J.; Dmitrovsky, E.; Miller, W. H. Jr; Tong, W. P.; Bajorin, D. F.; Scher, H. I.; Bosl, G. J.
    Cancer (1993)

    Fulltext@MSK | Save
  • Chemotherapy trials in recurrent primary intracranial germ cell tumors
    Journal Article

    Allen, J. C.; Bosl, G.; Walker, R.
    Journal of Neuro-Oncology (1985)

    Fulltext@MSK | Save